Within its first month of release, the premature ejaculation (PE) pill, Priligy, has sold out in Singapore.
Premature ejaculation (PE) is believed to be one of the most common male sexual health problems globally.
About one in three men in Singapore suffer from PE, according to a study on Premature Ejaculation Prevalence and Attitudes (PEPA) of Singapore men.
Priligy, to be taken orally, boasts the ability to treat one of the most common male sexual health problem.
The survey conducted prior to the launch of Priligy also found that 77 percent with PE never discussed their sexual health with a medical practitioner.
Its strong sales indicate that a growing number of local men are willing to discuss treatment options with doctors, says manufacturer, Janssen, a subsidiary of pharmaceutical giant Johnson & Johnson.